Liso-cel cost-effective for second-line relapsed/refractory lymphoma
Lisocabtagene maraleucel (liso-cel), a chimeric antigen receptor (CAR) T-cell remedy, is cost-effective for second-line diffuse giant B-cell lymphoma (DLBCL) remedy, ...
Tag: relapsedrefractory